Novel DIO1 Gene Mutation Acting as Phenotype Modifier for Novel Compound Heterozygous TPO Gene Mutations Causing Congenital Hypothyroidism
A family with congenital hypothyroidism was identified with two novel deleterious compound heterozygous thyroid peroxidase ( TPO ) mutations ( c.962C>A , and c.1577C>T ). Serum thyroid tests showed higher-than-expected serum-free thyroxine (T4) relative to TT3, while reverse triiodothyronine (...
Gespeichert in:
Veröffentlicht in: | Thyroid (New York, N.Y.) N.Y.), 2021-10, Vol.31 (10), p.1589-1591 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | A family with congenital hypothyroidism was identified with two novel deleterious compound heterozygous thyroid peroxidase (
TPO
) mutations (
c.962C>A
, and
c.1577C>T
). Serum thyroid tests showed higher-than-expected serum-free thyroxine (T4) relative to TT3, while reverse triiodothyronine (rT3) was also elevated. Two siblings manifested a more severe phenotype of developmental delay compared with another sibling and were found to harbor an additional novel heterozygous deleterious iodothyronine deiodinase 1 (
DIO1
) mutation (
c.395G>A
). In the context of L-T4 replacement, the decreased D1 activity results in abnormal thyroid hormone metabolism with decreased triiodothyronine (T3) generation from L-T4 and may result in decreased T3 bioavailability during critical stages of development. |
---|---|
ISSN: | 1050-7256 1557-9077 |
DOI: | 10.1089/thy.2021.0210 |